OKYO

insider transactions

OKYO Pharma Ltd — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 12, 26

Gabriele M Cerrone

Director, 10% Owner

$16.6K

15.0K sh · $1.11

Own +0%
Grant·A
Jun 8, 26

Willy Jules Simon

Director

$12.0K

6.5K sh · $1.85

Own +5%
Grant·A
Jun 8, 26

Keeren Rameshchandra Shah KEY

Chief Financial Officer

$74.0K

40.0K sh · $1.85

Own +8%
Grant·A
Jun 8, 26

Bernard Denoyer

Director

$6.5K

3.5K sh · $1.85

Own +11%
Grant·A
Jun 8, 26

Gabriele M Cerrone

Director, 10% Owner

$516.0K

300.0K sh · $1.72

Own +3%
Grant·A
Jun 8, 26

John P Brancaccio

Director

$12.0K

6.5K sh · $1.85

Own +5%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 12, 2026	Gabriele M Cerrone	Director, 10% Owner	Grant A	15.0K	+0%	$1.11	$16.6K
Jun 8, 2026	Willy Jules Simon	Director	Grant A	6.5K	+5%	$1.85	$12.0K
Jun 8, 2026	Keeren Rameshchandra Shah KEY	Chief Financial Officer	Grant A	40.0K	+8%	$1.85	$74.0K
Jun 8, 2026	Bernard Denoyer	Director	Grant A	3.5K	+11%	$1.85	$6.5K
Jun 8, 2026	Gabriele M Cerrone	Director, 10% Owner	Grant A	300.0K	+3%	$1.72	$516.0K
Jun 8, 2026	John P Brancaccio	Director	Grant A	6.5K	+5%	$1.85	$12.0K

About OKYO insider trading

This page tracks insider transactions for OKYO Pharma Ltd (OKYO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.